Loratadine / Pseudoephedrine Side Effects
Medically reviewed by Drugs.com. Last updated on Apr 9, 2024.
Applies to loratadine / pseudoephedrine: oral tablet extended release, oral tablet extended release 12 hr, oral tablet extended release 24 hr.
Other side effects
Some side effects of loratadine / pseudoephedrine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
- dizziness
- drowsiness
- nervousness
- trouble sleeping
Serious side effects
Along with its needed effects, loratadine/pseudoephedrine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
For healthcare professionals
Applies to loratadine / pseudoephedrine: oral tablet extended release.
General
The manufacturer has not provided adverse event information.[Ref]
References
1. (2019) "Product Information. Claritin-D 12 Hour (loratadine-pseudoephedrine)." Schering-Plough Corporation
More about loratadine / pseudoephedrine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (108)
- Drug images
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
- En español
Patient resources
Other brands
Claritin-D, Claritin-D 24 Hour, Loratadine-D 24 Hour, Claritin-D 12 Hour, ... +5 more
Professional resources
Other brands
Alavert D-12 Hour Allergy and Sinus
Related treatment guides
Further information
Loratadine/pseudoephedrine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.